Business Description
Applied BioCode Corp
ISIN : KYG0488D1051
Share Class Description:
TPE:6598: Reg ShsDescription
Applied BioCode Corp is engaged in designing, developing, manufacturing, and commercializing multiplex testing products for the in-vitro diagnostics market. The company's in-vitro diagnostic products focus on the molecular infectious disease segment of the market with assays that detect pathogens for gastrointestinal tract infections, respiratory infections, and sexually transmitted infections. The firm's products include barcoded magnetic bead technology (BMB). The BMB technology and detection systems assist in the development of multiplexed nucleic acids or protein detection assays. The company also develops applications for other areas of the diagnostics industry including life science research, agricultural testing, and veterinary markets.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 17.97 | |||||
| Equity-to-Asset | 0.64 | |||||
| Debt-to-Equity | 0.05 | |||||
| Debt-to-EBITDA | -0.29 | |||||
| Piotroski F-Score | 3/9 | |||||
| Altman Z-Score | 3.29 | |||||
| Beneish M-Score | -2.67 | |||||
| WACC vs ROIC | ||||||
Growth Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 7.8 | |||||
| 3-Year EBITDA Growth Rate | -19 | |||||
| 3-Year EPS without NRI Growth Rate | -14.7 | |||||
| 3-Year FCF Growth Rate | -4.7 | |||||
| 3-Year Book Growth Rate | -15.3 |
Momentum Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 55.47 | |||||
| 9-Day RSI | 56.52 | |||||
| 14-Day RSI | 53.88 | |||||
| 6-1 Month Momentum % | -14.81 | |||||
| 12-1 Month Momentum % | -29.04 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 6.99 | |||||
| Quick Ratio | 5.26 | |||||
| Cash Ratio | 4.84 | |||||
| Days Inventory | 486.72 | |||||
| Days Sales Outstanding | 52.13 | |||||
| Days Payable | 34.38 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -0.1 | |||||
| Shareholder Yield % | 0.82 |
Profitability Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 67.91 | |||||
| Operating Margin % | -51 | |||||
| Net Margin % | -44.82 | |||||
| FCF Margin % | -57.14 | |||||
| ROE % | -25.56 | |||||
| ROA % | -16.46 | |||||
| ROIC % | -57.94 | |||||
| ROC (Joel Greenblatt) % | -59.92 | |||||
| ROCE % | -17.95 |
GF Value Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 4.31 | |||||
| PB Ratio | 2.74 | |||||
| Price-to-Tangible-Book | 2.76 | |||||
| EV-to-EBIT | -6.61 | |||||
| EV-to-EBITDA | -10.37 | |||||
| EV-to-Revenue | 2.93 | |||||
| EV-to-FCF | -5.18 | |||||
| Price-to-Net-Current-Asset-Value | 3.53 | |||||
| Price-to-Net-Cash | 7.5 | |||||
| Earnings Yield (Greenblatt) % | -15.13 | |||||
| FCF Yield % | -13.3 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Applied BioCode Corp Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil NT$) | 393.962 | ||
| EPS (TTM) (NT$) | -2.16 | ||
| Beta | 0.64 | ||
| Volatility % | 23.83 | ||
| 14-Day RSI | 53.88 | ||
| 14-Day ATR (NT$) | 0.452666 | ||
| 20-Day SMA (NT$) | 20.23 | ||
| 12-1 Month Momentum % | -29.04 | ||
| 52-Week Range (NT$) | 19.2 - 28.4 | ||
| Shares Outstanding (Mil) | 81.78 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Applied BioCode Corp Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Applied BioCode Corp Stock Events
| Event | Date | Price(NT$) | ||
|---|---|---|---|---|
| No Event Data | ||||
Applied BioCode Corp Frequently Asked Questions
What is Applied BioCode Corp(TPE:6598)'s stock price today?
The current price of TPE:6598 is NT$20.70. The 52 week high of TPE:6598 is NT$28.40 and 52 week low is NT$19.20.
When is next earnings date of Applied BioCode Corp(TPE:6598)?
The next earnings date of Applied BioCode Corp(TPE:6598) is .
Does Applied BioCode Corp(TPE:6598) pay dividends? If so, how much?
Applied BioCode Corp(TPE:6598) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers